A carregar...

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer

In the last 6 years, since the first reports of an association between somatic mutations in epidermal growth factor receptor (EGFR) exons 19 and 21 and response to EGFR tyrosine kinase inhibitors (TKIs), treatment of non-small cell lung cancer (NSCLC) has changed dramatically. Based on laboratory an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dienstmann, Rodrigo, Martinez, Pablo, Felip, Enriqueta
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260814/
https://ncbi.nlm.nih.gov/pubmed/21444946
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!